Trump administration proposes new rules that strip away many of the rebate deals between pharma and PBMs, pushing discounts to consumers
After threatening for the past 2 years to do something dramatic to change the steady upward trajectory of list drug prices and slash out-of-pocket costs …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
